Screening for iron deficiency anemia (IDA) is important in managing pediatric patients with inflammatory bowel disease (IBD). Concerns related to adverse reactions may contribute to a reluctance to prescribe intravenous (IV) iron to treat IDA in this population.
No takes yet. Share an insight, caveat, or question.
Manokaran et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: